[1]
“Lived in Experience following Coronary Artery Bypass Grafting in selected Hospital Chengalpatttu”., Journal of Pharmaceutical Negative Results, pp. 136–140, Oct. 2022, doi: 10.47750/pnr.2022.13.S02.21.